Although previous studies are scarce, spinal meningiomas tend to have low MIB-1 indices (7–9) and there is no consensus on a specific MIB-1 index cut-off value for the prediction of tumor progression or recurrence in spinal meningiomas. The gene discussed is MIB1; the disease is neoplasm.